- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Ophthalmic Devices and Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Ophthalmic Devices and Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ophthalmic Devices and Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Ophthalmic Devices and Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Ophthalmic Devices and Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Ophthalmic Devices and Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ophthalmic Devices and Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ophthalmic Devices and Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zeiss, Haag Streit, Topcon, Nidek and Essilor, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Ophthalmic Devices and Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ophthalmic Devices
Ophthalmic Drugs
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Zeiss
Haag Streit
Topcon
Nidek
Essilor
Ziemer
Canon
Gulden Ophthalmics
Optovue
Quest Medical
Phoenix DeVentures
EyeKon Medical
FCI Ophthalmics
Atrion
Sterimedix
OPIA
IRIDEX
Jardon Eye Prosthetics
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Ophthalmic Devices and Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Ophthalmic Devices and Drugs, with revenue, gross margin and global market share of Ophthalmic Devices and Drugs from 2018 to 2023.
Chapter 3, the Ophthalmic Devices and Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Ophthalmic Devices and Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Ophthalmic Devices and Drugs.
Chapter 13, to describe Ophthalmic Devices and Drugs research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Ophthalmic Devices and Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Ophthalmic Devices and Drugs by Type
1.3.1 Overview: Global Ophthalmic Devices and Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Ophthalmic Devices and Drugs Consumption Value Market Share by Type in 2022
1.3.3 Ophthalmic Devices
1.3.4 Ophthalmic Drugs
1.4 Global Ophthalmic Devices and Drugs Market by Application
1.4.1 Overview: Global Ophthalmic Devices and Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Ophthalmic Devices and Drugs Market Size & Forecast
1.6 Global Ophthalmic Devices and Drugs Market Size and Forecast by Region
1.6.1 Global Ophthalmic Devices and Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Ophthalmic Devices and Drugs Market Size by Region, (2018-2029)
1.6.3 North America Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Zeiss
2.1.1 Zeiss Details
2.1.2 Zeiss Major Business
2.1.3 Zeiss Ophthalmic Devices and Drugs Product and Solutions
2.1.4 Zeiss Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zeiss Recent Developments and Future Plans
2.2 Haag Streit
2.2.1 Haag Streit Details
2.2.2 Haag Streit Major Business
2.2.3 Haag Streit Ophthalmic Devices and Drugs Product and Solutions
2.2.4 Haag Streit Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Haag Streit Recent Developments and Future Plans
2.3 Topcon
2.3.1 Topcon Details
2.3.2 Topcon Major Business
2.3.3 Topcon Ophthalmic Devices and Drugs Product and Solutions
2.3.4 Topcon Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Topcon Recent Developments and Future Plans
2.4 Nidek
2.4.1 Nidek Details
2.4.2 Nidek Major Business
2.4.3 Nidek Ophthalmic Devices and Drugs Product and Solutions
2.4.4 Nidek Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Nidek Recent Developments and Future Plans
2.5 Essilor
2.5.1 Essilor Details
2.5.2 Essilor Major Business
2.5.3 Essilor Ophthalmic Devices and Drugs Product and Solutions
2.5.4 Essilor Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Essilor Recent Developments and Future Plans
2.6 Ziemer
2.6.1 Ziemer Details
2.6.2 Ziemer Major Business
2.6.3 Ziemer Ophthalmic Devices and Drugs Product and Solutions
2.6.4 Ziemer Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ziemer Recent Developments and Future Plans
2.7 Canon
2.7.1 Canon Details
2.7.2 Canon Major Business
2.7.3 Canon Ophthalmic Devices and Drugs Product and Solutions
2.7.4 Canon Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Canon Recent Developments and Future Plans
2.8 Gulden Ophthalmics
2.8.1 Gulden Ophthalmics Details
2.8.2 Gulden Ophthalmics Major Business
2.8.3 Gulden Ophthalmics Ophthalmic Devices and Drugs Product and Solutions
2.8.4 Gulden Ophthalmics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Gulden Ophthalmics Recent Developments and Future Plans
2.9 Optovue
2.9.1 Optovue Details
2.9.2 Optovue Major Business
2.9.3 Optovue Ophthalmic Devices and Drugs Product and Solutions
2.9.4 Optovue Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Optovue Recent Developments and Future Plans
2.10 Quest Medical
2.10.1 Quest Medical Details
2.10.2 Quest Medical Major Business
2.10.3 Quest Medical Ophthalmic Devices and Drugs Product and Solutions
2.10.4 Quest Medical Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Quest Medical Recent Developments and Future Plans
2.11 Phoenix DeVentures
2.11.1 Phoenix DeVentures Details
2.11.2 Phoenix DeVentures Major Business
2.11.3 Phoenix DeVentures Ophthalmic Devices and Drugs Product and Solutions
2.11.4 Phoenix DeVentures Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Phoenix DeVentures Recent Developments and Future Plans
2.12 EyeKon Medical
2.12.1 EyeKon Medical Details
2.12.2 EyeKon Medical Major Business
2.12.3 EyeKon Medical Ophthalmic Devices and Drugs Product and Solutions
2.12.4 EyeKon Medical Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 EyeKon Medical Recent Developments and Future Plans
2.13 FCI Ophthalmics
2.13.1 FCI Ophthalmics Details
2.13.2 FCI Ophthalmics Major Business
2.13.3 FCI Ophthalmics Ophthalmic Devices and Drugs Product and Solutions
2.13.4 FCI Ophthalmics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 FCI Ophthalmics Recent Developments and Future Plans
2.14 Atrion
2.14.1 Atrion Details
2.14.2 Atrion Major Business
2.14.3 Atrion Ophthalmic Devices and Drugs Product and Solutions
2.14.4 Atrion Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Atrion Recent Developments and Future Plans
2.15 Sterimedix
2.15.1 Sterimedix Details
2.15.2 Sterimedix Major Business
2.15.3 Sterimedix Ophthalmic Devices and Drugs Product and Solutions
2.15.4 Sterimedix Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sterimedix Recent Developments and Future Plans
2.16 OPIA
2.16.1 OPIA Details
2.16.2 OPIA Major Business
2.16.3 OPIA Ophthalmic Devices and Drugs Product and Solutions
2.16.4 OPIA Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 OPIA Recent Developments and Future Plans
2.17 IRIDEX
2.17.1 IRIDEX Details
2.17.2 IRIDEX Major Business
2.17.3 IRIDEX Ophthalmic Devices and Drugs Product and Solutions
2.17.4 IRIDEX Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 IRIDEX Recent Developments and Future Plans
2.18 Jardon Eye Prosthetics
2.18.1 Jardon Eye Prosthetics Details
2.18.2 Jardon Eye Prosthetics Major Business
2.18.3 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Product and Solutions
2.18.4 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Jardon Eye Prosthetics Recent Developments and Future Plans
2.19 Santen Pharmaceutical
2.19.1 Santen Pharmaceutical Details
2.19.2 Santen Pharmaceutical Major Business
2.19.3 Santen Pharmaceutical Ophthalmic Devices and Drugs Product and Solutions
2.19.4 Santen Pharmaceutical Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Santen Pharmaceutical Recent Developments and Future Plans
2.20 Bausch Health
2.20.1 Bausch Health Details
2.20.2 Bausch Health Major Business
2.20.3 Bausch Health Ophthalmic Devices and Drugs Product and Solutions
2.20.4 Bausch Health Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Bausch Health Recent Developments and Future Plans
2.21 Takeda
2.21.1 Takeda Details
2.21.2 Takeda Major Business
2.21.3 Takeda Ophthalmic Devices and Drugs Product and Solutions
2.21.4 Takeda Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Takeda Recent Developments and Future Plans
2.22 Novartis
2.22.1 Novartis Details
2.22.2 Novartis Major Business
2.22.3 Novartis Ophthalmic Devices and Drugs Product and Solutions
2.22.4 Novartis Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Novartis Recent Developments and Future Plans
2.23 Genentech
2.23.1 Genentech Details
2.23.2 Genentech Major Business
2.23.3 Genentech Ophthalmic Devices and Drugs Product and Solutions
2.23.4 Genentech Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Genentech Recent Developments and Future Plans
2.24 Allergan
2.24.1 Allergan Details
2.24.2 Allergan Major Business
2.24.3 Allergan Ophthalmic Devices and Drugs Product and Solutions
2.24.4 Allergan Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Allergan Recent Developments and Future Plans
2.25 Sun Pharmaceutical Industries
2.25.1 Sun Pharmaceutical Industries Details
2.25.2 Sun Pharmaceutical Industries Major Business
2.25.3 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Product and Solutions
2.25.4 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
2.26 Actavis Generics
2.26.1 Actavis Generics Details
2.26.2 Actavis Generics Major Business
2.26.3 Actavis Generics Ophthalmic Devices and Drugs Product and Solutions
2.26.4 Actavis Generics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Actavis Generics Recent Developments and Future Plans
2.27 Regeneron Pharmaceuticals
2.27.1 Regeneron Pharmaceuticals Details
2.27.2 Regeneron Pharmaceuticals Major Business
2.27.3 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Product and Solutions
2.27.4 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.28 Pfizer
2.28.1 Pfizer Details
2.28.2 Pfizer Major Business
2.28.3 Pfizer Ophthalmic Devices and Drugs Product and Solutions
2.28.4 Pfizer Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 Pfizer Recent Developments and Future Plans
2.29 Johnson and Johnson
2.29.1 Johnson and Johnson Details
2.29.2 Johnson and Johnson Major Business
2.29.3 Johnson and Johnson Ophthalmic Devices and Drugs Product and Solutions
2.29.4 Johnson and Johnson Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Johnson and Johnson Recent Developments and Future Plans
2.30 Bausch and Lomb
2.30.1 Bausch and Lomb Details
2.30.2 Bausch and Lomb Major Business
2.30.3 Bausch and Lomb Ophthalmic Devices and Drugs Product and Solutions
2.30.4 Bausch and Lomb Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 Bausch and Lomb Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ophthalmic Devices and Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Ophthalmic Devices and Drugs by Company Revenue
3.2.2 Top 3 Ophthalmic Devices and Drugs Players Market Share in 2022
3.2.3 Top 6 Ophthalmic Devices and Drugs Players Market Share in 2022
3.3 Ophthalmic Devices and Drugs Market: Overall Company Footprint Analysis
3.3.1 Ophthalmic Devices and Drugs Market: Region Footprint
3.3.2 Ophthalmic Devices and Drugs Market: Company Product Type Footprint
3.3.3 Ophthalmic Devices and Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Ophthalmic Devices and Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Ophthalmic Devices and Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Ophthalmic Devices and Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
6.2 North America Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
6.3 North America Ophthalmic Devices and Drugs Market Size by Country
6.3.1 North America Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
7.2 Europe Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
7.3 Europe Ophthalmic Devices and Drugs Market Size by Country
7.3.1 Europe Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
7.3.3 France Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region
8.3.1 Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Region (2018-2029)
8.3.2 China Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
8.3.5 India Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
9.2 South America Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
9.3 South America Ophthalmic Devices and Drugs Market Size by Country
9.3.1 South America Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country
10.3.1 Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Ophthalmic Devices and Drugs Market Drivers
11.2 Ophthalmic Devices and Drugs Market Restraints
11.3 Ophthalmic Devices and Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Ophthalmic Devices and Drugs Industry Chain
12.2 Ophthalmic Devices and Drugs Upstream Analysis
12.3 Ophthalmic Devices and Drugs Midstream Analysis
12.4 Ophthalmic Devices and Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Ophthalmic Devices and Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Ophthalmic Devices and Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Ophthalmic Devices and Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Ophthalmic Devices and Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Zeiss Company Information, Head Office, and Major Competitors
Table 6. Zeiss Major Business
Table 7. Zeiss Ophthalmic Devices and Drugs Product and Solutions
Table 8. Zeiss Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Zeiss Recent Developments and Future Plans
Table 10. Haag Streit Company Information, Head Office, and Major Competitors
Table 11. Haag Streit Major Business
Table 12. Haag Streit Ophthalmic Devices and Drugs Product and Solutions
Table 13. Haag Streit Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Haag Streit Recent Developments and Future Plans
Table 15. Topcon Company Information, Head Office, and Major Competitors
Table 16. Topcon Major Business
Table 17. Topcon Ophthalmic Devices and Drugs Product and Solutions
Table 18. Topcon Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Topcon Recent Developments and Future Plans
Table 20. Nidek Company Information, Head Office, and Major Competitors
Table 21. Nidek Major Business
Table 22. Nidek Ophthalmic Devices and Drugs Product and Solutions
Table 23. Nidek Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Nidek Recent Developments and Future Plans
Table 25. Essilor Company Information, Head Office, and Major Competitors
Table 26. Essilor Major Business
Table 27. Essilor Ophthalmic Devices and Drugs Product and Solutions
Table 28. Essilor Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Essilor Recent Developments and Future Plans
Table 30. Ziemer Company Information, Head Office, and Major Competitors
Table 31. Ziemer Major Business
Table 32. Ziemer Ophthalmic Devices and Drugs Product and Solutions
Table 33. Ziemer Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Ziemer Recent Developments and Future Plans
Table 35. Canon Company Information, Head Office, and Major Competitors
Table 36. Canon Major Business
Table 37. Canon Ophthalmic Devices and Drugs Product and Solutions
Table 38. Canon Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Canon Recent Developments and Future Plans
Table 40. Gulden Ophthalmics Company Information, Head Office, and Major Competitors
Table 41. Gulden Ophthalmics Major Business
Table 42. Gulden Ophthalmics Ophthalmic Devices and Drugs Product and Solutions
Table 43. Gulden Ophthalmics Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Gulden Ophthalmics Recent Developments and Future Plans
Table 45. Optovue Company Information, Head Office, and Major Competitors
Table 46. Optovue Major Business
Table 47. Optovue Ophthalmic Devices and Drugs Product and Solutions
Table 48. Optovue Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Optovue Recent Developments and Future Plans
Table 50. Quest Medical Company Information, Head Office, and Major Competitors
Table 51. Quest Medical Major Business
Table 52. Quest Medical Ophthalmic Devices and Drugs Product and Solutions
Table 53. Quest Medical Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Quest Medical Recent Developments and Future Plans
Table 55. Phoenix DeVentures Company Information, Head Office, and Major Competitors
Table 56. Phoenix DeVentures Major Business
Table 57. Phoenix DeVentures Ophthalmic Devices and Drugs Product and Solutions
Table 58. Phoenix DeVentures Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Phoenix DeVentures Recent Developments and Future Plans
Table 60. EyeKon Medical Company Information, Head Office, and Major Competitors
Table 61. EyeKon Medical Major Business
Table 62. EyeKon Medical Ophthalmic Devices and Drugs Product and Solutions
Table 63. EyeKon Medical Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. EyeKon Medical Recent Developments and Future Plans
Table 65. FCI Ophthalmics Company Information, Head Office, and Major Competitors
Table 66. FCI Ophthalmics Major Business
Table 67. FCI Ophthalmics Ophthalmic Devices and Drugs Product and Solutions
Table 68. FCI Ophthalmics Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. FCI Ophthalmics Recent Developments and Future Plans
Table 70. Atrion Company Information, Head Office, and Major Competitors
Table 71. Atrion Major Business
Table 72. Atrion Ophthalmic Devices and Drugs Product and Solutions
Table 73. Atrion Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Atrion Recent Developments and Future Plans
Table 75. Sterimedix Company Information, Head Office, and Major Competitors
Table 76. Sterimedix Major Business
Table 77. Sterimedix Ophthalmic Devices and Drugs Product and Solutions
Table 78. Sterimedix Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Sterimedix Recent Developments and Future Plans
Table 80. OPIA Company Information, Head Office, and Major Competitors
Table 81. OPIA Major Business
Table 82. OPIA Ophthalmic Devices and Drugs Product and Solutions
Table 83. OPIA Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. OPIA Recent Developments and Future Plans
Table 85. IRIDEX Company Information, Head Office, and Major Competitors
Table 86. IRIDEX Major Business
Table 87. IRIDEX Ophthalmic Devices and Drugs Product and Solutions
Table 88. IRIDEX Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. IRIDEX Recent Developments and Future Plans
Table 90. Jardon Eye Prosthetics Company Information, Head Office, and Major Competitors
Table 91. Jardon Eye Prosthetics Major Business
Table 92. Jardon Eye Prosthetics Ophthalmic Devices and Drugs Product and Solutions
Table 93. Jardon Eye Prosthetics Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Jardon Eye Prosthetics Recent Developments and Future Plans
Table 95. Santen Pharmaceutical Company Information, Head Office, and Major Competitors
Table 96. Santen Pharmaceutical Major Business
Table 97. Santen Pharmaceutical Ophthalmic Devices and Drugs Product and Solutions
Table 98. Santen Pharmaceutical Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Santen Pharmaceutical Recent Developments and Future Plans
Table 100. Bausch Health Company Information, Head Office, and Major Competitors
Table 101. Bausch Health Major Business
Table 102. Bausch Health Ophthalmic Devices and Drugs Product and Solutions
Table 103. Bausch Health Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Bausch Health Recent Developments and Future Plans
Table 105. Takeda Company Information, Head Office, and Major Competitors
Table 106. Takeda Major Business
Table 107. Takeda Ophthalmic Devices and Drugs Product and Solutions
Table 108. Takeda Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Takeda Recent Developments and Future Plans
Table 110. Novartis Company Information, Head Office, and Major Competitors
Table 111. Novartis Major Business
Table 112. Novartis Ophthalmic Devices and Drugs Product and Solutions
Table 113. Novartis Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Novartis Recent Developments and Future Plans
Table 115. Genentech Company Information, Head Office, and Major Competitors
Table 116. Genentech Major Business
Table 117. Genentech Ophthalmic Devices and Drugs Product and Solutions
Table 118. Genentech Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Genentech Recent Developments and Future Plans
Table 120. Allergan Company Information, Head Office, and Major Competitors
Table 121. Allergan Major Business
Table 122. Allergan Ophthalmic Devices and Drugs Product and Solutions
Table 123. Allergan Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Allergan Recent Developments and Future Plans
Table 125. Sun Pharmaceutical Industries Company Information, Head Office, and Major Competitors
Table 126. Sun Pharmaceutical Industries Major Business
Table 127. Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Product and Solutions
Table 128. Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Sun Pharmaceutical Industries Recent Developments and Future Plans
Table 130. Actavis Generics Company Information, Head Office, and Major Competitors
Table 131. Actavis Generics Major Business
Table 132. Actavis Generics Ophthalmic Devices and Drugs Product and Solutions
Table 133. Actavis Generics Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Actavis Generics Recent Developments and Future Plans
Table 135. Regeneron Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 136. Regeneron Pharmaceuticals Major Business
Table 137. Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Product and Solutions
Table 138. Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. Regeneron Pharmaceuticals Recent Developments and Future Plans
Table 140. Pfizer Company Information, Head Office, and Major Competitors
Table 141. Pfizer Major Business
Table 142. Pfizer Ophthalmic Devices and Drugs Product and Solutions
Table 143. Pfizer Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 144. Pfizer Recent Developments and Future Plans
Table 145. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 146. Johnson and Johnson Major Business
Table 147. Johnson and Johnson Ophthalmic Devices and Drugs Product and Solutions
Table 148. Johnson and Johnson Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Johnson and Johnson Recent Developments and Future Plans
Table 150. Bausch and Lomb Company Information, Head Office, and Major Competitors
Table 151. Bausch and Lomb Major Business
Table 152. Bausch and Lomb Ophthalmic Devices and Drugs Product and Solutions
Table 153. Bausch and Lomb Ophthalmic Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Bausch and Lomb Recent Developments and Future Plans
Table 155. Global Ophthalmic Devices and Drugs Revenue (USD Million) by Players (2018-2023)
Table 156. Global Ophthalmic Devices and Drugs Revenue Share by Players (2018-2023)
Table 157. Breakdown of Ophthalmic Devices and Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 158. Market Position of Players in Ophthalmic Devices and Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 159. Head Office of Key Ophthalmic Devices and Drugs Players
Table 160. Ophthalmic Devices and Drugs Market: Company Product Type Footprint
Table 161. Ophthalmic Devices and Drugs Market: Company Product Application Footprint
Table 162. Ophthalmic Devices and Drugs New Market Entrants and Barriers to Market Entry
Table 163. Ophthalmic Devices and Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 164. Global Ophthalmic Devices and Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 165. Global Ophthalmic Devices and Drugs Consumption Value Share by Type (2018-2023)
Table 166. Global Ophthalmic Devices and Drugs Consumption Value Forecast by Type (2024-2029)
Table 167. Global Ophthalmic Devices and Drugs Consumption Value by Application (2018-2023)
Table 168. Global Ophthalmic Devices and Drugs Consumption Value Forecast by Application (2024-2029)
Table 169. North America Ophthalmic Devices and Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 170. North America Ophthalmic Devices and Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 171. North America Ophthalmic Devices and Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 172. North America Ophthalmic Devices and Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 173. North America Ophthalmic Devices and Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 174. North America Ophthalmic Devices and Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 175. Europe Ophthalmic Devices and Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 176. Europe Ophthalmic Devices and Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 177. Europe Ophthalmic Devices and Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 178. Europe Ophthalmic Devices and Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 179. Europe Ophthalmic Devices and Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 180. Europe Ophthalmic Devices and Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 181. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 182. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 183. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 184. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 185. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 186. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 187. South America Ophthalmic Devices and Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 188. South America Ophthalmic Devices and Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 189. South America Ophthalmic Devices and Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 190. South America Ophthalmic Devices and Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 191. South America Ophthalmic Devices and Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 192. South America Ophthalmic Devices and Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 193. Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 194. Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 195. Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 196. Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 197. Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 198. Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 199. Ophthalmic Devices and Drugs Raw Material
Table 200. Key Suppliers of Ophthalmic Devices and Drugs Raw Materials
List of Figures
Figure 1. Ophthalmic Devices and Drugs Picture
Figure 2. Global Ophthalmic Devices and Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Ophthalmic Devices and Drugs Consumption Value Market Share by Type in 2022
Figure 4. Ophthalmic Devices
Figure 5. Ophthalmic Drugs
Figure 6. Global Ophthalmic Devices and Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Ophthalmic Devices and Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Ophthalmic Devices and Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Ophthalmic Devices and Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Ophthalmic Devices and Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Ophthalmic Devices and Drugs Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Ophthalmic Devices and Drugs Consumption Value Market Share by Region in 2022
Figure 16. North America Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Ophthalmic Devices and Drugs Revenue Share by Players in 2022
Figure 22. Ophthalmic Devices and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Ophthalmic Devices and Drugs Market Share in 2022
Figure 24. Global Top 6 Players Ophthalmic Devices and Drugs Market Share in 2022
Figure 25. Global Ophthalmic Devices and Drugs Consumption Value Share by Type (2018-2023)
Figure 26. Global Ophthalmic Devices and Drugs Market Share Forecast by Type (2024-2029)
Figure 27. Global Ophthalmic Devices and Drugs Consumption Value Share by Application (2018-2023)
Figure 28. Global Ophthalmic Devices and Drugs Market Share Forecast by Application (2024-2029)
Figure 29. North America Ophthalmic Devices and Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Ophthalmic Devices and Drugs Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Ophthalmic Devices and Drugs Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Ophthalmic Devices and Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. France Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Ophthalmic Devices and Drugs Consumption Value Market Share by Region (2018-2029)
Figure 46. China Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. India Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Ophthalmic Devices and Drugs Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Ophthalmic Devices and Drugs Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Ophthalmic Devices and Drugs Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Ophthalmic Devices and Drugs Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Ophthalmic Devices and Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. Ophthalmic Devices and Drugs Market Drivers
Figure 64. Ophthalmic Devices and Drugs Market Restraints
Figure 65. Ophthalmic Devices and Drugs Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Ophthalmic Devices and Drugs in 2022
Figure 68. Manufacturing Process Analysis of Ophthalmic Devices and Drugs
Figure 69. Ophthalmic Devices and Drugs Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
